Financial Summary -
Optimapharm Research Ro S.r.l.
Unique identification code:11268190
Registration number:J1998011591402
Nace:7210
Sales - Ron
2.060.525
Net Profit - Ron
102.000
Employees
9
Open Account
Company Optimapharm Research Ro S.r.l. with Fiscal Code 11268190
recorded a turnover of 2024 of
2.060.525,
with a net profit of
102.000
and having an average number of employees of
9.
The company operates in the field of Cercetare-dezvoltare în ştiinţe naturale şi inginerie having the NACE code 7210.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Optimapharm Research Ro S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
1.575.048
1.206.382
1.431.650
1.262.139
889.215
835.813
931.236
3.112.494
1.217.154
2.060.525
Total Income - EUR
1.576.015
1.370.328
1.448.066
1.265.794
892.309
845.334
950.192
3.312.354
1.308.313
2.082.203
Total Expenses - EUR
1.583.331
1.358.097
1.426.833
1.235.659
882.159
837.061
897.667
2.834.271
1.210.353
1.962.001
Gross Profit/Loss - EUR
-7.315
12.231
21.232
30.135
10.150
8.273
52.525
478.084
97.960
120.202
Net Profit/Loss - EUR
-11.784
961
12.307
21.296
5.339
4.569
43.439
401.111
81.624
102.000
Employees
18
18
21
18
17
18
15
0
8
9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 70.2%, from 1.217.154 euro in the year 2023, to 2.060.525 euro in 2024.
The Net Profit increased by 20.832 euro, from 81.624 euro in 2023, to 102.000 in the last year.
Check the financial reports for the company - Optimapharm Research Ro S.r.l.
Financial Rating - OPTIMAPHARM RESEARCH RO S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Optimapharm Research Ro S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Optimapharm Research Ro S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Optimapharm Research Ro S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Optimapharm Research Ro S.r.l. - CUI 11268190
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
117.595
14.821
8.838
3.818
2.282
4.605
7.780
9.625
4.992
4.503
Current Assets
80.136
144.680
172.655
152.413
132.060
153.249
197.176
1.705.859
1.444.394
1.171.359
Inventories
127
508
0
0
0
0
558
2.611
8.668
737
Receivables
33.739
89.683
59.167
61.417
52.613
111.196
104.446
328.458
1.219.080
967.261
Cash
46.270
54.489
113.488
90.996
79.447
42.054
92.172
1.374.790
216.647
203.360
Shareholders Funds
124.008
66.873
78.048
97.912
101.356
104.004
141.497
543.047
623.024
721.542
Social Capital
78.740
77.937
76.618
75.212
73.756
72.357
70.753
70.972
70.757
70.362
Debts
73.723
100.644
103.445
58.319
32.986
53.851
63.459
1.147.203
766.853
400.160
Income in Advance
0
0
0
0
0
0
0
703
140
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7210 - 7210"
CAEN Financial Year
7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.171.359 euro in 2024 which includes Inventories of
737 euro, Receivables of
967.261 euro and cash availability of
203.360 euro.
The company's Equity was valued at
721.542 euro, while total Liabilities amounted to
400.160 euro.
Equity increased by 102.000 euro, from 623.024 euro in 2023, to 721.542 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Optimapharm Research Ro S.r.l.